Press Room Archive

Vascular & Transplant Specialists Turn to SRS Software, Inc. for Digital Chart Solutions

MONTVALE, NJ, February 24, 2005 - SRS Software, Inc. today announced that Vascular & Transplant Specialists (VTS), the largest vascular surgery group in the United States, has contracted for SRS' Freedom Chart Manager™. All 15 surgeons, as well as professional and administrative support staff in the group's seven locations in southeastern Virginia and northeastern North Carolina, will be using SRS' enterprise digital chart management and workflow solution.

"The size and scope of our surgical practice were significant factors in our decision to move to a paperless environment with SRS," states Marc Glickman, MD, VTS' president and managing director. "Since teamwork, availability and communication are key aspects of our practice, we needed a proven electronic solution that could give us immediate, universal access to all pertinent patient clinical data. For the best return on our investment, the software also had to be affordable and easily learned and used by all VTS staff," continues Dr. Glickman.

Against the national backdrop of a 50 percent failure rate for EMRs, SRS has established an industry benchmark of success with the onset of its fifth consecutive year without a de-installation.

"Our 100 percent successful implementation and provider acceptance of Freedom Chart Manager™ offer proof positive that SRS delivers on its promises," asserts Evan Steele, SRS' CEO. "Where others fail, SRS succeeds. Price, ease-of-use, and cost savings distinguish SRS from its competitors."

Three key elements support broad provider acceptance of SRS and underscore SRS' ongoing success: minimal training, no data entry and ubiquitous access. An independently documented 20-minute training period per provider substantiates the product's ease of learning and user friendly format. Employing powerful document imaging technology, SRS Freedom Chart Manager™ requires no data entry from physicians and staff. Additionally, SRS' digitized paperless charts, including doctor notes, medication refills and lab results, can be securely accessed remotely by providers 24/7/365.

SRS markets its Freedom Chart Manager™ solution to ambulatory and hospital-based enterprises nationwide.

About SRS Software, Inc.
SRS Freedom Chart Manager™ is a proven digital chart management and business workflow solution for healthcare enterprises that is better than EMR. SRS automatically converts charts into a new paperless environment, rapidly cuts costs and immediately improves workflow without high cost or complexity. With an unprecedented 100% successful installation and utilization rate for five consecutive years, SRS serves thousands of physicians in over 30 medical specialties nationwide. Independently documented as requiring less than 20 minutes to train a provider, SRS doesn't slow physicians down or change the way they see patients or document visits. SRS Freedom Chart Manager™ is easy to learn, easy to use, and easy to afford at a fraction of the cost, training time, and learning curve required by the competition.

For more information on SRS or to schedule a demonstration, e-mail info@srssoft.com or call 800.288.8369.

About Vascular & Transplant Specialists
In 2002, Vascular & Transplant Specialists (VTS) brought together the resources of the Vascular Division of Norfolk Surgical Group with Virginia Vascular Associates to create Virginia's premier provider of vascular and kidney transplant services. Since 1979, the group's Board-certified surgeons, physician assistants, vascular nurses, vascular technologists, and administrative staff have served referring physicians and their patients throughout southeastern Virginia and northeastern North Carolina. VTS' surgeons are internationally recognized experts in vascular surgery, transplantation, surgical education, and vascular research. All VTS surgeons are actively involved in the advanced training of vascular fellows at Eastern Virginia Medical School and are helping to advance the field of vascular surgery by conducting clinical research projects in partnership with several major biotechnology companies.